Jan Lubinski,Joanne Kotsopoulos,Pal Moller,Tuya Pal,Andrea Eisen,Larissa Peck,Beth Y. Karlan,Amber Aeilts,Charis Eng,Louise Bordeleau,William D. Foulkes,Nadine Tung,Fergus J. Couch,Robert Fruscio,Teresa Ramon y Cajal,Christian F. Singer,Susan L. Neuhausen,Dana Zakalik,Cezary Cybulski,Jacek Gronwald,Tomasz Huzarski,Klaudia Stempa,Jeffrey Dungan,Carey Cullinane,Olufunmilayo I. Olopade,Kelly Metcalfe,Ping Sun,Steven A. Narod,Kevin Sweet,Leigha Senter,Howard Saal,Lea Velsher,Susan Armel,Jeanna McCuaig,Seema Panchal,Aletta Poll,Edmond Lemire,Kim Serfas,Robert Reilly,Josephine Costalas,Stephanie Cohen,Joanne Blum,

Abstract:Importance Magnetic resonance imaging (MRI) surveillance is offered to women with a pathogenic variant in the BRCA1 or BRCA2 gene who face a high lifetime risk of breast cancer. Surveillance with MRI is effective in downstaging breast cancers, but the association of MRI surveillance with mortality risk has not been well defined. Objective To compare breast cancer mortality rates in women with a BRCA1 or BRCA2 sequence variation who entered an MRI surveillance program with those who did not. Design, Setting, and Participants Women with a BRCA1 or BRCA2 sequence variation were identified from 59 participating centers in 11 countries. Participants completed a baseline questionnaire between 1995 and 2015 and a follow-up questionnaire every 2 years to document screening histories, incident cancers, and vital status. Women who had breast cancer, a screening MRI examination, or bilateral mastectomy prior to enrollment were excluded. Participants were followed up from age 30 years (or the date of the baseline questionnaire, whichever was later) until age 75 years, the last follow-up, or death from breast cancer. Data were analyzed from January 1 to July 31, 2023. Exposures Entrance into an MRI surveillance program. Main Outcomes and Measures Cox proportional hazards modeling was used to estimate the hazard ratios (HRs) and 95% CIs for breast cancer mortality associated with MRI surveillance compared with no MRI surveillance using a time-dependent analysis. Results A total of 2488 women (mean [range] age at study entry 41.2 [30-69] years), with a sequence variation in the BRCA1 (n = 2004) or BRCA2 (n = 484) genes were included in the analysis. Of these participants, 1756 (70.6%) had at least 1 screening MRI examination and 732 women (29.4%) did not. After a mean follow-up of 9.2 years, 344 women (13.8%) developed breast cancer and 35 women (1.4%) died of breast cancer. The age-adjusted HRs for breast cancer mortality associated with entering an MRI surveillance program were 0.20 (95% CI, 0.10-0.43; P &lt; .001) for women with BRCA1 sequence variations and 0.87 (95% CI, 0.10-17.25; P = .93) for women with BRCA2 sequence variations. Conclusion and Relevance Results of this cohort study suggest that among women with a BRCA1 sequence variation, MRI surveillance was associated with a significant reduction in breast cancer mortality compared with no MRI surveillance. Further studies of women with BRCA2 sequence variations are needed to ascertain these women obtain the same benefits associated with MRI surveillance.

Breast Implant Rupture Surveillance Practices among Plastic Surgeons in Publicly Funded Healthcare Systems

Outcomes of In-Office, High Resolution, Ultrasound Silicone Breast Implant Surveillance by Plastic Surgeons

Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients

Plastic Surgeons’ Perspective on the FDA Breast Implant Regulatory Mandates

Ultrasonic elastography for the prevention of breast implant rupture: Detection of an increase with stiffness over implantation time

Exploration of Point-of-Care Ultrasonography for Silicone Breast Implant Rupture Detection and Classification

[Breast implants in France. New regulations, and qualitative and quantitative study of breast implants sold between 1995 and 2004]

Low Rate of Annual Check-Ups Results in Delayed Presentation of Ruptured Implants

A Comparative Assessment of Three Planes of Implant Placement in Breast Augmentation: A Bayesian Analysis

Non-contrast MRI and post-mastectomy silicone breast implant rupture: preventing false positive diagnoses

International importance of robust breast device registries

Testing Mechanical Properties of Silicone Gel-Filled Breast Implants and Their Degradation

Comparison of Clinical Breast Exam to Breast MRI Surveillance in Patients Following Nipple-Sparing Mastectomy

MRI for Evaluation of Complications of Breast Augmentation

Silicone implant and fibrous capsule assessment based on water-fat-silicone chemical shift encoding-based species separation in breast MRI

Unnecessary Explantation of IDEAL IMPLANT Structured Saline Breast Implants Prompted byRadiologic Misdiagnosis of Rupture

Data quality assessment of the Dutch Breast Implant Registry by automated data verification using medical billing data

Breast Reduction with Implants or Augmentation Reduction: Patient-Reported Outcomes from a Single-Centre Retrospective Cohort Analysis

Surgical and Patient-Reported Outcomes of 694 Two-Stage Prepectoral versus Subpectoral Breast Reconstructions

The impact of cosmetic tourism across one year on an NHS breast surgery unit

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations